Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Ethanolamine-oleate | hsa00030 | Pentose phosphate pathway | 5.07E-03 | 3 | P60891, P51854, P37837 | PRPS1, TKTL1, TALDO1 | More | | Ethanolamine-oleate | hsa00220 | Arginine biosynthesis | 1.54E-02 | 2 | P05089, P49448 | ARG1, GLUD2 | More | | Ethanolamine-oleate | hsa00500 | Starch and sucrose metabolism | 3.86E-02 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Ethanolamine-oleate | hsa00630 | Glyoxylate and dicarboxylate metabolism | 1.29E-02 | 2 | P40925, P15104 | MDH1, GLUL | More | | Ethanolamine-oleate | hsa00790 | Folate biosynthesis | 4.05E-02 | 2 | Q92820, P42330 | GGH, AKR1C3 | More | | Ethanolamine-oleate | hsa00910 | Nitrogen metabolism | 2.93E-02 | 2 | P22748, P49448 | CA4, GLUD2 | More | | Ethanolamine-oleate | hsa00970 | Aminoacyl-tRNA biosynthesis | 5.32E-03 | 3 | O95363, P54136, Q15046 | FARS2, RARS1, KARS | More | | Ethanolamine-oleate | hsa00983 | Drug metabolism - other enzymes | 6.73E-05 | 3 | P04183, P32320, P05164 | TK1, CDA, MPO | More | | Ethanolamine-oleate | hsa04060 | Cytokine-cytokine receptor interaction | 1.74E-04 | 17 | P14784, P27930, P14778, P08476, P26842, Q06643, Q13651, Q9HBE5, P25024, Q9UBD3, P47992, P01375, P09341, P19875, P18510, P01730, Q93038 | IL2RB, IL1R2, IL1R1, INHBA, CD27, LTB, IL10RA, IL21R, CXCR1, XCL2, XCL1, TNF, CXCL1, CXCL2, IL1RN, CD4, TNFRSF25 | More | | Ethanolamine-oleate | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 3.36E-04 | 9 | P09341, P19875, P25024, P25025, P47992, Q9UBD3, Q13651, P14784, P01375 | CXCL1, CXCL2, CXCR1, CXCR2, XCL1, XCL2, IL10RA, IL2RB, TNF | More | | Ethanolamine-oleate | hsa04062 | Chemokine signaling pathway | 5.37E-03 | 9 | P25024, P09341, P19875, P07948, P42338, P19174, P63218, P50151, P43250 | CXCR1, CXCL1, CXCL2, LYN, PIK3CB, PLCG1, GNG5, GNG10, GRK6 | More | | Ethanolamine-oleate | hsa04064 | NF-kappa B signaling pathway | 3.72E-06 | 16 | P10415, O00463, P14778, P01375, P19174, Q04759, Q9UDY8, Q16548, P07948, P06239, Q13315, P24522, O75293, P09341, P19875, Q06643 | BCL2, TRAF5, IL1R1, TNF, PLCG1, PRKCQ, MALT1, BCL2A1, LYN, LCK, ATM, GADD45A, GADD45B, CXCL1, CXCL2, LTB | More | | Ethanolamine-oleate | hsa04071 | Sphingolipid signaling pathway | 2.25E-02 | 5 | P21453, Q9H228, P01375, Q13362, P10415 | S1PR1, EDG8, TNF, PPP2R5C, BCL2 | More | | Ethanolamine-oleate | hsa04080 | Neuroactive ligand-receptor interaction | 6.23E-03 | 8 | P08311, Q15722, P21453, Q9H228, O00398, P21462, P21730, Q16581 | CTSG, LTB4R, S1PR1, EDG8, P2RY10, FPR1, C5AR1, C3AR1 | More | | Ethanolamine-oleate | hsa04145 | Phagosome | 2.35E-02 | 6 | Q15080, P05164, P78380, O60603, P35443, P13765 | NCF4, MPO, OLR1, TLR2, THBS4, HLA-DOB | More | | Ethanolamine-oleate | hsa04210 | Apoptosis | 2.59E-02 | 8 | P10415, O76075, P01375, P24522, Q16548, P43234, P18848, Q14643 | BCL2, DFFB, TNF, GADD45A, BCL2A1, CTSO, ATF4, ITPR1 | More | | Ethanolamine-oleate | hsa04213 | Longevity regulating pathway - multiple species | 3.85E-02 | 4 | P42338, Q9Y4H2, P11142, Q13547 | PIK3CB, IRS2, HSPA8, HDAC1 | More | | Ethanolamine-oleate | hsa04340 | Hedgehog signaling pathway | 4.63E-02 | 3 | P22694, Q13635, P10415 | PRKACB, PTCH1, BCL2 | More | | Ethanolamine-oleate | hsa04612 | Antigen processing and presentation | 1.41E-07 | 8 | P13765, P48382, P26715, P26717, Q13241, O43908, P01732, P01375 | HLA-DOB, RFX5, KLRC1, KLRC2, KLRD1, KLRC4, CD8A, TNF | More | | Ethanolamine-oleate | hsa04613 | Neutrophil extracellular trap formation | 1.72E-02 | 10 | O60603, P05164, P08246, Q9UM07, Q6FI13, Q15080, P20160, P08311, P21730, P21462 | TLR2, MPO, ELA2, PADI4, H2AC18; H2AC19, NCF4, AZU1, CTSG, C5AR1, FPR1 | More | | Ethanolamine-oleate | hsa04640 | Hematopoietic cell lineage | 2.66E-04 | 13 | P13612, P14778, P27930, P11215, P15144, P25063, P07766, P09693, P01732, P01730, P09564, P13765, P01375 | ITGA4, IL1R1, IL1R2, ITGAM, ANPEP, CD24, CD3E, CD3G, CD8A, CD4, CD7, HLA-DOB, TNF | More | | Ethanolamine-oleate | hsa04650 | Natural killer cell mediated cytotoxicity | 3.48E-08 | 11 | P19174, P01375, P06239, O60880, P20963, P42338, Q13241, P26718, O75015, P26717, P26715 | PLCG1, TNF, LCK, SH2D1A, CD247, PIK3CB, KLRD1, KLRK1, FCGR3B, KLRC2, KLRC1 | More | | Ethanolamine-oleate | hsa04657 | IL-17 signaling pathway | 8.05E-04 | 7 | O00463, Q16539, P49841, P09341, P14780, P80188, P01375 | TRAF5, MAPK14, GSK3B, CXCL1, MMP9, LCN2, TNF | More | | Ethanolamine-oleate | hsa04658 | Th1 and Th2 cell differentiation | 8.53E-12 | 14 | Q04759, P07766, P20963, P09693, Q16539, P19174, P01730, P06239, Q14765, P23771, Q9UL17, P14784, P13765, Q13761 | PRKCQ, CD3E, CD247, CD3G, MAPK14, PLCG1, CD4, LCK, STAT4, GATA3, TBX21, IL2RB, HLA-DOB, RUNX3 | More | | Ethanolamine-oleate | hsa04659 | Th17 cell differentiation | 1.06E-08 | 14 | Q04759, Q16539, P19174, P01730, P06239, P14784, P13765, P14778, Q9HBE5, Q9UL17, P23771, P07766, P09693, P20963 | PRKCQ, MAPK14, PLCG1, CD4, LCK, IL2RB, HLA-DOB, IL1R1, IL21R, TBX21, GATA3, CD3E, CD3G, CD247 | More | | Ethanolamine-oleate | hsa04660 | T cell receptor signaling pathway | 3.88E-07 | 15 | P01375, Q04759, P42338, O95267, Q08881, P19174, P07766, P20963, P09693, P01730, P01732, Q13191, P06239, Q16539, P49841 | TNF, PRKCQ, PIK3CB, RASGRP1, ITK, PLCG1, CD3E, CD247, CD3G, CD4, CD8A, CBLB, LCK, MAPK14, GSK3B | More | | Ethanolamine-oleate | hsa04662 | B cell receptor signaling pathway | 1.07E-02 | 5 | P42338, P60033, P07948, P21854, Q8N149 | PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Ethanolamine-oleate | hsa04664 | Fc epsilon RI signaling pathway | 1.29E-02 | 4 | P42338, P07948, P19174, P09917 | PIK3CB, LYN, PLCG1, ALOX5 | More | | Ethanolamine-oleate | hsa04668 | TNF signaling pathway | 3.19E-02 | 7 | P01375, O00463, Q16539, P09341, P20749, Q13077, P14780 | TNF, TRAF5, MAPK14, CXCL1, BCL3, TRAF1, MMP9 | More | | Ethanolamine-oleate | hsa04720 | Long-term potentiation | 2.62E-02 | 3 | P18848, P22694, Q14643 | ATF4, PRKACB, ITPR1 | More | | Ethanolamine-oleate | hsa04724 | Glutamatergic synapse | 2.81E-02 | 4 | P43003, P63218, P50151, P15104 | SLC1A3, GNG5, GNG10, GLUL | More | | Ethanolamine-oleate | hsa04725 | Cholinergic synapse | 3.86E-02 | 4 | P22694, Q14643, P18848, P10415 | PRKACB, ITPR1, ATF4, BCL2 | More | | Ethanolamine-oleate | hsa04750 | Inflammatory mediator regulation of TRP channels | 4.06E-03 | 8 | P14778, P22694, Q16539, P19174, P42338, Q14643, P24723, Q04759 | IL1R1, PRKACB, MAPK14, PLCG1, PIK3CB, ITPR1, PRKCH, PRKCQ | More | | Ethanolamine-oleate | hsa04912 | GnRH signaling pathway | 2.62E-02 | 3 | P18848, Q14643, P22694 | ATF4, ITPR1, PRKACB | More | | Ethanolamine-oleate | hsa04913 | Ovarian steroidogenesis | 4.05E-02 | 2 | P42330, P22694 | AKR1C3, PRKACB | More | | Ethanolamine-oleate | hsa04915 | Estrogen signaling pathway | 1.67E-03 | 5 | P14780, P22694, P18848, Q14643, P10415 | MMP9, PRKACB, ATF4, ITPR1, BCL2 | More | | Ethanolamine-oleate | hsa04918 | Thyroid hormone synthesis | 7.24E-04 | 3 | P22694, P18848, Q14643 | PRKACB, ATF4, ITPR1 | More | | Ethanolamine-oleate | hsa04922 | Glucagon signaling pathway | 2.11E-02 | 4 | P22694, P06737, P18848, Q14643 | PRKACB, PYGL, ATF4, ITPR1 | More | | Ethanolamine-oleate | hsa04925 | Aldosterone synthesis and secretion | 4.95E-02 | 3 | Q14643, P18848, P22694 | ITPR1, ATF4, PRKACB | More | | Ethanolamine-oleate | hsa04927 | Cortisol synthesis and secretion | 3.17E-05 | 3 | Q14643, P18848, P22694 | ITPR1, ATF4, PRKACB | More | | Ethanolamine-oleate | hsa04928 | Parathyroid hormone synthesis, secretion and action | 9.12E-04 | 5 | Q14643, P22694, P23771, P18848, P10415 | ITPR1, PRKACB, GATA3, ATF4, BCL2 | More | | Ethanolamine-oleate | hsa04934 | Cushing syndrome | 4.06E-02 | 5 | Q14643, P22694, P49841, Q9UJU2, O00170 | ITPR1, PRKACB, GSK3B, LEF1, AIP | More | | Ethanolamine-oleate | hsa04964 | Proximal tubule bicarbonate reclamation | 2.93E-02 | 2 | P22748, P49448 | CA4, GLUD2 | More | | Ethanolamine-oleate | hsa04973 | Carbohydrate digestion and absorption | 1.29E-02 | 2 | O43451, P42338 | MGAM, PIK3CB | More | | Ethanolamine-oleate | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 2.78E-03 | 5 | P09341, P19875, P19174, P25024, P07948 | CXCL1, CXCL2, PLCG1, CXCR1, LYN | More | | Ethanolamine-oleate | hsa05134 | Legionellosis | 1.29E-02 | 4 | P11215, P11142, P09341, P19875 | ITGAM, HSPA8, CXCL1, CXCL2 | More | | Ethanolamine-oleate | hsa05135 | Yersinia infection | 4.26E-02 | 6 | P13612, P06239, Q16539, P01375, P49841, P01732 | ITGA4, LCK, MAPK14, TNF, GSK3B, CD8A | More | | Ethanolamine-oleate | hsa05144 | Malaria | 1.80E-02 | 4 | O60603, P01375, P35443, P26718 | TLR2, TNF, THBS4, KLRK1 | More | | Ethanolamine-oleate | hsa05146 | Amoebiasis | 1.05E-08 | 13 | Q13751, P09341, P19875, P14778, P27930, P01375, O60603, P42338, P11215, P05089, P22694, P12814, P08311 | LAMB3, CXCL1, CXCL2, IL1R1, IL1R2, TNF, TLR2, PIK3CB, ITGAM, ARG1, PRKACB, ACTN1, CTSG | More | | Ethanolamine-oleate | hsa05152 | Tuberculosis | 4.71E-02 | 6 | P48382, O60603, P01375, P10415, P13765, Q9UDY8 | RFX5, TLR2, TNF, BCL2, HLA-DOB, MALT1 | More | | Ethanolamine-oleate | hsa05163 | Human cytomegalovirus infection | 2.64E-02 | 7 | P42338, P63218, P50151, P01106, P14778, Q13651, P30101 | PIK3CB, GNG5, GNG10, MYC, IL1R1, IL10RA, PDIA3 | More | | Ethanolamine-oleate | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 7.60E-03 | 8 | P42338, P63218, P50151, P09341, P19875, P19174, P07948, P01106 | PIK3CB, GNG5, GNG10, CXCL1, CXCL2, PLCG1, LYN, MYC | More | | Ethanolamine-oleate | hsa05169 | Epstein-Barr virus infection | 1.27E-02 | 9 | P01106, Q13547, P42338, P07948, P30101, Q13761, O75293, P07766, P20963 | MYC, HDAC1, PIK3CB, LYN, PDIA3, RUNX3, GADD45B, CD3E, CD247 | More | | Ethanolamine-oleate | hsa05170 | Human immunodeficiency virus 1 infection | 3.15E-02 | 8 | P42338, P63218, P50151, P30101, P01730, P19174, P07766, P20963 | PIK3CB, GNG5, GNG10, PDIA3, CD4, PLCG1, CD3E, CD247 | More | | Ethanolamine-oleate | hsa05202 | Transcriptional misregulation in cancer | 3.93E-05 | 12 | Q15532, Q13315, P14780, P27930, Q15744, Q16548, O15550, P05164, P12838, P08246, Q9C0K0, P24522 | SS18, ATM, MMP9, IL1R2, CEBPE, BCL2A1, UTX, MPO, DEFA4, ELA2, BCL11B, GADD45A | More | | Ethanolamine-oleate | hsa05217 | Basal cell carcinoma | 3.39E-02 | 4 | Q13635, P49841, Q9UJU2, P24522 | PTCH1, GSK3B, LEF1, GADD45A | More | | Ethanolamine-oleate | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 6.30E-05 | 10 | P42338, O95267, P19174, P07766, P20963, P09693, P06239, Q04759, Q16539, P01730 | PIK3CB, RASGRP1, PLCG1, CD3E, CD247, CD3G, LCK, PRKCQ, MAPK14, CD4 | More | | Ethanolamine-oleate | hsa05310 | Asthma | 5.10E-06 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Ethanolamine-oleate | hsa05321 | Inflammatory bowel disease | 1.12E-09 | 7 | O60603, P01375, P13765, Q14765, Q9UL17, P23771, Q9HBE5 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3, IL21R | More | | Ethanolamine-oleate | hsa05322 | Systemic lupus erythematosus | 3.90E-02 | 6 | P08246, P08311, P01375, P13765, Q16778, P12814 | ELA2, CTSG, TNF, HLA-DOB, HIST2H2BE, ACTN1 | More | | Ethanolamine-oleate | hsa05323 | Rheumatoid arthritis | 2.72E-02 | 4 | P01375, P13765, P09341, O60603 | TNF, HLA-DOB, CXCL1, TLR2 | More | | Ethanolamine-oleate | hsa05332 | Graft-versus-host disease | 2.66E-06 | 4 | P13765, P01375, P26715, Q13241 | HLA-DOB, TNF, KLRC1, KLRD1 | More | | |